Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
DiaMedica Therapeutics Inc.
DMAC
$
9.72
13%
Sun June 13th, 2021
16:47
Analysis
DiaMedica: Undercovered Stroke Drug Company With Decent Data
Seeking Alpha
Mon May 17th, 2021
16:28
DiaMedica Stock Gains On Green Signal To Start Pivotal DM199 Trial In Ischemic Stroke
Benzinga
Sun May 9th, 2021
20:31
Earnings
Analysis
DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2021 Results - Earnings Call Transcript
Seeking Alpha
Mon March 15th, 2021
13:23
Analysis
DiaMedica Therapeutics (DMAC) Investor Presentation - Slideshow
Seeking Alpha
Thu March 11th, 2021
18:11
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha
Sun November 8th, 2020
05:54
Earnings
Analysis
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Fri November 6th, 2020
17:14
Earnings
Analysis
DiaMedica Therapeutics Inc. 2020 Q3 - Results - Earnings Call Presentation
Seeking Alpha
Wed August 12th, 2020
14:48
Earnings
Analysis
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Wed July 8th, 2020
12:18
Analysis
Diamedica Therapeutics started at buy with $14 stock price target at Maxim Group
MarketWatch
